Acuitas Chemicals Limited has announced the inauguration of a new, state-of-the-art pilot plant at its Unit 1 facility in Sachin, Surat. This development is crucial for supporting the company’s research and development efforts, particularly for new product trials and validations. The facility is equipped with a dedicated area designed for Occupational Exposure Band (OEB) 4 containment, enabling Acuitas to develop and scale-up highly potent intermediates for the manufacturing of high potency active pharmaceutical ingredients.
Acuitas Chemicals Launches Advanced Pilot Plant Facility
Acuitas Chemicals Limited has officially inaugurated a new, state-of-the-art pilot plant at its manufacturing facility located in Unit 1 – Sachin, Surat. The company announced this significant development on September 4, 2026, marking a key milestone in its expansion and R&D capabilities.
Enhanced R&D and Production Capabilities
The newly commissioned pilot plant is designed to bolster the company’s research and development initiatives, focusing on new product trials and validation processes. A critical feature of this new facility is a dedicated area engineered for Occupational Exposure Band (OEB) 4 containment. This advanced capability will empower Acuitas Chemicals to effectively develop and scale-up the manufacturing of highly potent intermediates. These intermediates are essential for the production of high potency active pharmaceutical ingredients (HPAPIs), a growing segment in the pharmaceutical industry.
Strategic Importance for Future Growth
The inauguration of this pilot plant underscores Acuitas Chemicals’ commitment to innovation and its strategic focus on high-value pharmaceutical ingredients. The enhanced capacity for handling potent compounds is expected to support the company’s pipeline of new products and strengthen its position in the market.
Source: BSE
